German
|
English
|
French
Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "Eylea" (18)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
Aflibercept (S01LA05) 18 products
WHO-DDD
DrugBank.ca
L
IP
Eylea, 2 mg/0,05 ml
Durchstechflasche(n)
500.00
563.25
10 %
Injection solution: Afliberceptum 2mg / 0.05ml
Bayer (Schweiz) AG
B / SL / SO
FB
G
L
IP
Eylea 2 mg/0.05 ml
500.00
563.25
10 %
Lösung zur intravitrealen Injektion in einer Fertigspritze: Afliberceptum 2mg / 50µl
Bayer (Schweiz) AG
B / SL / SO
FB
G
L
IP
Mynzepli 40 mg/ml
417.33
478.45
10 %
Injection solution: Afliberceptum 2mg / 0.05ml
Advanz Pharma
Specialty Medicine
Switzerland GmbH
B / SL / SG
FB
G
L
IP
Pavblu 40 mg/ml
417.33
478.45
10 %
Injection solution: Afliberceptum 2mg / 0.05ml
Amgen Switzerland AG
B / SL / SG
FB
G
L
IP
Afqlir 40 mg/ml
417.33
478.45
10 %
Injection solution in prefilled syringe: Afliberceptum 2mg / 50µl
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
L
Ahzantive 2 mg/0.05 ml
417.33
478.45
10 %
Injection solution in prefilled syringe: Afliberceptum 2mg / 0.05ml
Medvisis Switzerland AG
B / SL / SG
FB
G
L
IP
Mynzepli 40 mg/ml
417.33
478.45
10 %
Injection solution in prefilled syringe: Afliberceptum 2mg / 0.05ml
Advanz Pharma
Specialty Medicine
Switzerland GmbH
B / SL / SG
FB
G
L
IP
Pavblu 40 mg/ml
417.33
478.45
10 %
Injection solution in prefilled syringe: Afliberceptum 2mg / 0.05ml
Amgen Switzerland AG
B / SL / SG
FB
G
L
IP
Eylea 8 mg/0.07 ml
500.00
560.20
10 %
Injection solution: Afliberceptum 8mg / 0.07ml
Bayer (Schweiz) AG
B / SL
FB
G
L
IP
Eylea 8 mg/0.07ml
500.00
560.20
10 %
Injection solution in prefilled syringe: Afliberceptum 8mg / 0.07ml
Bayer (Schweiz) AG
B / SL
FB
G
IP
Aflivis 40 mg/ml
417.33
478.45
k.A.
Injection solution: Afliberceptum 2mg / 50µl
OmniVision AG
B
FB
G
IP
Afqlir 40 mg/ml
k.A.
Injection solution: Afliberceptum 2mg / 0.05ml
Sandoz
Pharmaceuticals AG
B
FB
G
Yesafili 40 mg/ml
k.A.
Injection solution: Afliberceptum 2mg / 0.05ml
Medius AG
B
FB
G
IP
Aflivis 40 mg/ml
417.33
478.45
k.A.
Injection solution in prefilled syringe: Afliberceptum 2mg / 50µl
OmniVision AG
B
FB
G
Baiama 40 mg/ml
k.A.
Injection solution: Afliberceptum 2mg / 0.05ml
Horus Pharma Suisse SA
B
FB
G
Eydenzelt 40 mg / ml
k.A.
Injection solution: Afliberceptum 2mg / 0.05ml
iQone Healthcare
Switzerland SA
B
FB
G
IP
Eylea 2 mg/0.05 ml
syringe(s)
913.48
1063.35
k.A.
Lösung zur intravitrealen Injektion in einer Fertigspritze: Afliberceptum 2mg / 50µl
Bayer (Schweiz) AG
B
FB
G
Eydenzelt 40mg / ml
k.A.
solution injectable en seringue préremplie: Afliberceptum 2mg / 0.05ml
iQone Healthcare
Switzerland SA
B
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2026
©ywesee GmbH
Settings
|
Help
|
Login
|
Contact
|
Home
